VYNE Therapeutics  logo
VYNE Therapeutics VYNE
$ 3.03 4.48%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

VYNE Therapeutics EV/EBITDA Ratio 2011-2024 | VYNE

Annual EV/EBITDA Ratio VYNE Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-0.407 -2.05 - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-0.407 -2.05 -1.23